The present invention relates to new acetylinic piperazine compounds of formula I, their pharmaceutically acceptable salts, and hydrates:
wherein R
1
, R
2
, R
3
, R
4
, M, and n are as defined in the description. The invention also relates to processes for the preparation of the compounds and to new intermediates employed in the preparation, pharmaceutical compositions containing the compounds, and to the use of the compounds in therapy.
本发明涉及公式I的新的
乙炔基
哌嗪化合物,其药学上可接受的盐和
水合物,其中R1、R2、R3、R4、M和n如描述中所定义。本发明还涉及制备该化合物的过程以及用于制备的新中间体,含有该化合物的药物组合物以及在治疗中使用该化合物的用途。